A Randomised Open-label Multi-centre Comparative Study to Evaluate Cycle Control of 2 Dosages of Estetrol Combined With Either P1 or P2, Compared to a Combined Oral Contraceptive Containing E2V and DNG.
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Estetrol (Primary) ; Drospirenone; Estradiol valerate/dienogest; Levonorgestrel
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms FIESTA study
- Sponsors Estetra S.A.
- 27 Feb 2012 Actual patient number (396) added as reported by ClinicalTrials.gov.
- 23 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 23 Sep 2011 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov.